BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33994086)

  • 1. Development of a rabbit monocyte activation test as an alternative to the rabbit pyrogen test and its application in the analysis of plasma-derived products.
    Kim JH; Jung K; Kim J; Lee J; Kim H; Song H; Han K; Park S; Ahn C; Kim CW
    Biologicals; 2021 Jun; 71():20-30. PubMed ID: 33994086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of pyrogenic response of lipoteichoic acid by the monocyte activation test and the rabbit pyrogen test.
    Gimenes I; Caldeira C; Presgrave OA; de Moura WC; Villas Boas MH
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):356-60. PubMed ID: 26232706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of pyrogen assays by testing products exhibiting low endotoxin recovery.
    Thurman TL; Lahti CJ; Mateffy JM; Forng RY; von Wintzingerode F; Silva LM; Deutschmann SM; Mozier N
    ALTEX; 2023; 40(1):117-124. PubMed ID: 35796330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applicability of the Monocyte Activation Test (MAT) for hyperimmune sera in the routine of the quality control laboratory: Comparison with the Rabbit Pyrogen Test (RPT).
    da Silva CC; Presgrave OA; Hartung T; de Moraes AM; Delgado IF
    Toxicol In Vitro; 2016 Apr; 32():70-5. PubMed ID: 26688320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte-activation test to reliably measure the pyrogenic content of a vaccine: An in vitro pyrogen test to overcome in vivo limitations.
    Valentini S; Santoro G; Baffetta F; Franceschi S; Paludi M; Brandini E; Gherardini L; Serruto D; Capecchi B
    Vaccine; 2019 Jun; 37(29):3754-3760. PubMed ID: 30448065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of the monocyte activation test for evaluating pyrogenicity of tick-borne encephalitis virus vaccine.
    Etna MP; Giacomini E; Rizzo F; Severa M; Ricci D; Shaid S; Lambrigts D; Valentini S; Galli Stampino L; Alleri L; Gaggioli A; Von Hunolstein C; Spreitzer I; Coccia EM
    ALTEX; 2020; 37(4):532-544. PubMed ID: 32488289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of pyrogen detection tests in the quality control of meningococcal conjugate vaccines: The applicability of the Monocyte Activation Test.
    Fernandes Silva V; da Silva Guedes Junior D; da Silveira IA; Santos Almeida A; de Paiva Conte F; Fernandes Delgado I; Caldeira Silva C; França Presgrave OA; Antunes de Mattos K
    Altern Lab Anim; 2018 Nov; 46(5):255-272. PubMed ID: 30488711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardized pyrogen testing of medical products with the bacterial endotoxin test (BET) as a substitute for rabbit Pyrogen testing (RPT): A scoping review.
    Spoladore J; Gimenes I; Bachinski R; Negherbon JP; Hartung T; Granjeiro JM; Alves GG
    Toxicol In Vitro; 2021 Aug; 74():105160. PubMed ID: 33831473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of pyrogenicity testing: Phasing out the rabbit pyrogen test. A meeting report.
    Cirefice G; Schütte K; Spreitzer I; Charton E; Shaid S; Viviani L; Rubbrecht M; Manou I
    Biologicals; 2023 Nov; 84():101702. PubMed ID: 37643507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Material-mediated pyrogens in medical devices: Applicability of the in vitro Monocyte Activation Test.
    Borton LK; Coleman KP
    ALTEX; 2018; 35(4):453-463. PubMed ID: 29901209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitations of the rabbit pyrogen test for assessing meningococcal OMV based vaccines.
    Vipond C; Findlay L; Feavers I; Care R
    ALTEX; 2016; 33(1):47-53. PubMed ID: 26626274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the monocyte activation test with three therapeutic monoclonal antibodies.
    Daniels R; Van der Elst W; Dieltjens N; Appels T; So CK; Nys T; Voeten L; Breugelmans P; Molenaar-de Backer MWA; Gitz E; Poole S; Patel M
    ALTEX; 2022; 39(4):621–635. PubMed ID: 35502618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of Interference During In Vitro Pyrogen Detection: Development and Characterization of a Cell-Based Assay.
    Palma L; Rossetti F; Dominici S; Buondelmonte C; Rocchi MB; Rizzardi GP; Vallanti G; Magnani M
    Assay Drug Dev Technol; 2017; 15(2):64-76. PubMed ID: 27996302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applicability of the Monocyte Activation Test (MAT) in the quality control of the 17DD yellow fever vaccine.
    de Mattos KA; Navega ECA; Silva VF; Almeida AS; da Silva CC; Presgrave OAF; Junior DDSG; Delgado IF
    Altern Lab Anim; 2018 Mar; 46(1):23-37. PubMed ID: 29553795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of monocyte activation test supplemented with human serum compared to fetal bovine serum.
    Molenaar-de Backer MWA; Gitz E; Dieker M; Doodeman P; Ten Brinke A
    ALTEX; 2021; 38(2):307-315. PubMed ID: 33118606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human monocytoid cell lines as indicators of endotoxin: comparison with rabbit pyrogen and Limulus amoebocyte lysate assay.
    Eperon S; De Groote D; Werner-Felmayer G; Jungi TW
    J Immunol Methods; 1997 Sep; 207(2):135-45. PubMed ID: 9368640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Monocyte Activation Test as an Alternative to the Rabbit Pyrogen Test for Mono- and Multi-Component
    Carson D; Myhill S; Palmieri E; Necchi F; Rijpkema S; Micoli F; Nordgren IK; Rossi O; Vipond C
    Microorganisms; 2021 Jun; 9(7):. PubMed ID: 34202832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrogen testing revisited on occasion of the 25th anniversary of the whole blood monocyte activation test.
    Hartung T
    ALTEX; 2021; 38(1):3-19. PubMed ID: 33452528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble β-(1,3)-glucans enhance LPS-induced response in the monocyte activation test, but inhibit LPS-mediated febrile response in rabbits: Implications for pyrogenicity tests.
    Pardo-Ruiz Z; Menéndez-Sardiñas DE; Pacios-Michelena A; Gabilondo-Ramírez T; Montero-Alejo V; Perdomo-Morales R
    Eur J Pharm Sci; 2016 Jan; 81():18-26. PubMed ID: 26428698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro alternative for reactogenicity assessment of outer membrane vesicle based vaccines.
    Molenaar-de Backer MWA; Doodeman P; Rezai F; Verhagen LM; van der Ark A; Plagmeijer EM; Metz B; van Vlies N; Ophorst O; Raeven RHM
    Sci Rep; 2023 Aug; 13(1):12675. PubMed ID: 37542099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.